<DOC>
	<DOCNO>NCT00674050</DOCNO>
	<brief_summary>This study investigate effect inhale albuterol &amp; fluticasone one dose TI Inhalation Powder . A total 12 eligible subject enrol .</brief_summary>
	<brief_title>A Study Designed Determine Drugs Albuterol ( Salbutamol ) Fluticasone Have Effect Pharmacokinetics Investigational Product TechnosphereÂ® Insulin Inhalation Powder Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Subjects must fast blood glucose ( BG ) level le 6.1 mmol/L FEV1/ FVC = LLN TLC = 80 % Predicted DLco ( unc ) = 80 % Predicted ( Miller ) No significant improvement pre postbronchodilator spirometry ( defined increase = 12 % = 200 mL FEV1 FVC ) Screening FEV1 = 80 % ( NHANES III Predicted History diabetes mellitus Previous exposure inhale insulin product Any known pulmonary disease inability perform PFT maneuver meet recommended American Thoracic Society ( ATS ) standard acceptability repeatability criterion Respiratory tract infection within 8 week prior Screening/Visit 1 Major organ system diseases include seizure , heart failure , uncontrolled hypertension , aneurysm , cancer within past 5 year , liver disease , anemia autoimmune disorder Clinically significant abnormality screen laboratory evaluation Female subject pregnant , lactating , plan become pregnant clinical trial period practice adequate birth control Unable and/or unlikely comprehend use investigational device study follow study instruction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Healthy Males Females subject</keyword>
</DOC>